Unusual case of Parkes-Weber syndrome in a patient with spontaneous subarachnoid hemorrhage
Abstract
Introduction. Parkes-Weber syndrome (PWS) is a complex and rare genetic disease of combined vascular malformations that primarily occur in the extremities and can involve the pelvic blood vessels. In extremely rare cases, the disease is manifested by endocranial and spinal involvement. The treatment of such patients represents a challenge for neurosurgical centers and requires a multidisciplinary approach. Case report. We present the case of a 46-year-old male patient admitted to the emergency department due to spontaneous subarachnoid hemorrhage (SAH), moderate flaccid paraparesis, and urinary incontinence. The patient was previously diagnosed with PWS, while the genetic evaluation proved the RASA1 gene mutation. Furthermore, he experienced a spontaneous SAH and was hospitalized 26 years ago, while six years ago, he underwent a right nephrectomy due to multiple hilar aneurysms of the right renal artery and its branches. Digital subtraction angiography of the endocranium was performed, which detected no aneurysmal dilatations or arteriovenous malformations (AVM). The magnetic resonance imaging recorded spinal intradural AVM in the vertebral levels between T12 and L3, which completely filled the dural sac. After the conservative treatment, there was a significant improvement in the patient’s neurological and clinical condition. Conclusion. To the best of our knowledge, this is the only case report of a patient with PWS who had a spinal intradural AVM and spontaneous SAH without high-output heart failure and with a history of a previous nephrectomy.
References
Banzić I, Branković M, Maksimović Ž, Davidović L, Marković M, Rančić Z. Parkes Weber syndrome-Diagnostic and management paradigms: A systematic review. Phlebology 2017; 32(6): 371–83.
Naganathan S, Tadi P. Klippel-Trenaunay-Weber Syndrome [updated 2023 Apr 14]. In: StatPearls [Internet]. Treasure Is-land (FL): StatPearls Publishing; 2023. [accessed on 2023 Au-gust 25] Available from: https://www.ncbi.nlm.nih.gov/book
s/NBK558989/
Patel R, Durant EJ, Freed R. Parkes-Weber syndrome in the emergency department. BMJ Case Rep 2021; 14(9): e241649.
Iizuka Y, Suzuki M, Komura S, Takada T, Shimoji K. Conus me-dullaris spinal arteriovenous malformation in a patient with Klippel-Trenaunay-Weber syndrome. A case report and review of the literature. Interv Neuroradiol 2008; 14(2): 185–90.
Hackett ML, Anderson CS. Health outcomes 1 year after sub-arachnoid hemorrhage: an international population-based study. The Australian Cooperative Research on Subarachnoid Hemorrhage Study Group. Neurology 2000; 55(5): 658‒62.
de Rooij NK, Rinkel GJ, Dankbaar JW, Frijns CJ. Delayed cere-bral ischemia after subarachnoid hemorrhage: a systematic re-view of clinical, laboratory, and radiological predictors. Stroke 2013; 44(1): 43‒54.
Deoraj S, Moutzouris DA, Bellini MI. Prevalence, Mechanisms, Treatment, and Complications of Hypertension Postliving Kidney Donation. Biomed Res Int 2021; 2021: 5460672.
Dubow J, Fink ME. Impact of hypertension on stroke. Curr Atheroscler Rep 2011; 13(4): 298‒305.
Provencio JJ, Fu X, Siu A, Rasmussen PA, Hazen SL, Ransohoff RM. CSF neutrophils are implicated in the development of vasospasm in subarachnoid hemorrhage. Neurocrit Care 2010; 12(2): 244‒51.
Kasius KM, Frijns CJ, Algra A, Rinkel GJ. Association of platelet and leukocyte counts with delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage. Cerebrovasc Dis 2010; 29(6): 576‒83.
Al-Mufti F, Amuluru K, Damodara N, Dodson V, Roh D, Agarwal S, et al. Admission neutrophil-lymphocyte ratio predicts delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage. J Neurointerv Surg 2019; 11(11): 1135‒40.
Kostić A, Stojanov D, Stefanović I, Novak V, Kostić E, Benedeto-Stojanov D, et al. Complications after angiogram-negative sub-arachnoid haemorrhage: comparative study of pretruncal and nonpretruncal hemorrhage patients. Srp Arh Celok Lek 2012; 140(1‒2): 8‒13.
Marquardt G, Niebauer T, Schick U, Lorenz R. Long term follow up after perimesencephalic subarachnoid haemorrhage. J Neu-rol Neurosurg Psychiatry 2000; 69(1): 127‒30.
Aghayev K, Iqbal SM, Asghar W, Shahmurzada B, Vrionis FD. Advances in CSF shunt devices and their assessment for the treatment of hydrocephalus. Expert Rev Med Devices 2021; 18(9): 865‒73.
Tomei KL. The evolution of cerebrospinal fluid shunts: advances in technology and technique. Pediatr Neurosurg 2017; 52(6): 369‒80.
Del Bigio MR, Di Curzio DL. Nonsurgical therapy for hydro-cephalus: a comprehensive and critical review. Fluids Barriers CNS 2016; 13: 3.
Kramer AH, Jenne CN, Zygun DA, Roberts DJ, Hill MD, Holodinsky JK, et al. Intraventricular fibrinolysis with tissue plasminogen activator is associated with transient cerebrospi-nal fluid inflammation: a randomized controlled trial. J Cereb Blood Flow Metab 2015; 35(8): 1241–8.
Butnariu LI, Gorduza EV, Florea L, Țarcă E, Moisă ȘM, Trandafir LM, et al. The Genetic Architecture of Vascular Anomalies: Current Data and Future Therapeutic Perspectives Correlated with Molecular Mechanisms. Int J Mol Sci 2022; 23(20): 12199.